Novo Nordisk A/S | 销售和管理费用



Selling And Administration Expenses 更改 日
Bausch Health Companies USD 850M 18M 2024-09
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.42B 324.7M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Novo Nordisk 16.59B 501M 2024-09
Novo Nordisk DKK 16.59B 501M 2024-09
Pacira USD 79.61M 5.28M 2024-12
Sanofi EUR 2.22B 980M 2025-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12



Novo Nordisk A/S 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.